Rebound hypertension and withdrawal associated with discontinuation of an infusion of epidural clonidine.

A small percentage of patients with cancer pain suffer from refractory pain despite aggressive therapy. 1 Intraspinal administration of opioids and local anesthetic agents may be helpful in such settings, but their use may be limited by side effects such as motor block and hemodynamic instability. 2,3 Clonidine is a centrally acting α 2 -adrenergic agonist with established analgesic effects 4,5 and has synergistic effects with spinal opioids 6,7 and spinal local anesthetics. 8,9 Epidural clonidine produces analgesia by a spinal mechanism in patients after surgery and in those with cancer pain, 10 and it appears to be an effective treatment for severe cancer pain in patients for whom other treatments are ineffective. 11 Although the risk of acute withdrawal and rebound hypertension is well recognized with sudden cessation of systemically administered clonidine, 12 no such reports exist with regard to epidurally administered clonidine. We describe a case of acute withdrawal and rebound hypertension after abrupt cessation of epidural clonidine in a patient with intractable cancer pain.

[1]  J. Eisenach,et al.  Epidural clonidine analgesia for intractable cancer pain , 1995, Pain.

[2]  T. Meert,et al.  Potentiation of the Analgesic Properties of Fentanyl-like Opioids with α2-Adrenoceptor Agonists in Rats , 1994, Anesthesiology.

[3]  R. Portenoy,et al.  Cancer pain management current strategy , 1993, Cancer.

[4]  J. Eisenach,et al.  Hemodynamic and Analgesic Actions of Epidurally Administered Clonidine , 1993, Anesthesiology.

[5]  H. Kehlet,et al.  Epidural clonidine enhances postoperative analgesia from a combined low-dose epidural bupivacaine and morphine regimen. , 1992, Anesthesia and analgesia.

[6]  J. Moore,et al.  Extradural clonidine infusions for analgesia after total hip replacement. , 1992, British journal of anaesthesia.

[7]  S. D. Du Pen,et al.  Management of patients receiving combined epidural morphine and bupivacaine for the treatment of cancer pain. , 1992, Journal of pain and symptom management.

[8]  N. Janjan,et al.  Epidural opiates and local anesthetics for the management of cancer pain , 1991, Pain.

[9]  D. Reis,et al.  Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. , 1990, The Journal of pharmacology and experimental therapeutics.

[10]  J. Eisenach,et al.  Epidural clonidine analgesia for intractable cancer pain: phase I. , 1989, Anesthesiology.

[11]  C. Touboul,et al.  Postoperative Analgesia with Extradural Clonidine , 1989, British journal of anaesthesia.

[12]  C. Winckler,et al.  COMPARISON OF THE EFFECTS OF MORPHINE, CLONIDINE AND A COMBINATION OF MORPHINE AND CLONIDINE ADMINISTERED EPIDURALLY FOR POSTOPERATIVE ANALGESIA , 1989 .

[13]  M. Ossipov,et al.  Antinociceptive Interactions Between Alphha2‐Adrenergic and Opiate Agonists at the Spinal Level in Rodents , 1989, Anesthesia and analgesia.

[14]  A. Dickenson,et al.  Alpha 2-adrenoceptor modulation of nociception in rat spinal cord: location, effects and interactions with morphine. , 1987, European journal of pharmacology.

[15]  E. Conway,et al.  CLONIDINE: UNDERSTANDING ITS DISPOSITION, SITES AND MECHANISM OF ACTION , 1987, Clinical and experimental pharmacology & physiology.

[16]  R. Saunders,et al.  Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. , 1986, Journal of neurosurgery.

[17]  J. Reid,et al.  Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. , 1984, Hypertension.

[18]  M. Lokhandwala,et al.  Involvement of Central Noradrenergic Mechanisms in the Rebound Hypertension Following Clonidine Withdrawal , 1982, Journal of cardiovascular pharmacology.

[19]  P. Guyenet,et al.  Inhibition of sympathetic preganglionic neurons by catecholamines and clonidine: mediation by an alpha-adrenergic receptor , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  J. Schwartz,et al.  The nucleus reticularis lateralis: a region highly sensitive to clonidine. , 1981, European journal of pharmacology.

[21]  B. Bunney,et al.  Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine , 1975, Brain Research.

[22]  S. Julius,et al.  Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. , 1973, American heart journal.

[23]  Detre Km.  Intrathecal morphine and clonidine for control of intractable cancer pain. A case report. , 1988 .

[24]  R. Ritz,et al.  Prejunctional α2-Adrenoceptors and Norepinephrine Release in the Forearm of Normal Humans , 1985 .

[25]  M. Weber.  Discontinuation Syndrome Following Cessation of Treatment with Clonidine and Other Antihypertensive Agents , 1980, Journal of cardiovascular pharmacology.